Breaking News Instant updates and real-time market news.

SQ

Square

$32.55

0.5465 (1.71%)

, CLDR

Cloudera

$15.72

-0.06 (-0.38%)

10:21
10/12/17
10/12
10:21
10/12/17
10:21

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Square (SQ) initiated with an Outperform at Oppenheimer. 2. Cloudera (CLDR) initiated with a Neutral at Mizuho. 3. Tesaro (TSRO) initiated with a Buy at H.C. Wainwright. 4. TechnipFMC (FTI) coverage transferred with a Market Perform at Raymond James. 5. Tactile Systems (TCMD) initiated with a Buy at Guggenheim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

SQ

Square

$32.55

0.5465 (1.71%)

CLDR

Cloudera

$15.72

-0.06 (-0.38%)

TSRO

Tesaro

$117.91

-0.31 (-0.26%)

FTI

TechnipFMC

$26.82

-0.45 (-1.65%)

TCMD

Tactile Systems

$30.99

-0.15 (-0.48%)

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

  • 25

    Oct

  • 26

    Oct

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

SQ Square
$32.55

0.5465 (1.71%)

10/11/17
OPCO
10/11/17
INITIATION
Target $35
OPCO
Outperform
Square initiated with an Outperform at Oppenheimer
Oppenheimer analyst Jed Kelly initiated Square with an Outperform and $35 price target saying he sees continued upside from execution on core initiates to expand into multiple revenue channels. The analyst believes Square's cohesive user experience is enabling the company to create a differentiated product that is in the early stages of utilizing its vast payment data to build an ecosystem for small businesses that can obtain products such as loans, marketing services, inventory management and ecommerce solutions.
09/13/17
09/13/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN) initiated with a Buy at Loop Capital. 2. Square (SQ) initiated with an Overweight at Cantor. 3. Molson Coors (TAP) initiated with a Sell at Berenberg. 4. Build-A-Bear (BBW) initiated with a Buy at Jefferies. 5. Regis (RGS) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/13/17
CANT
09/13/17
INITIATION
Target $31
CANT
Overweight
Cantor starts Square with Overweight rating, $31 price target
Cantor Fitzgerald analyst Joseph Foresi last night initiated shares of Square with an Overweight rating and $31 price target. The analyst sees the company's increasing market penetration, end-user growth and improving margin profile driving multiple expansion. He notes the shares trade at a discount to PayPal (PYPL) and the group.
09/12/17
CANT
09/12/17
INITIATION
Target $31
CANT
Overweight
Square initiated with an Overweight at Cantor
Cantor initiated Square with an Overweight and a $31 price target.
CLDR Cloudera
$15.72

-0.06 (-0.38%)

10/11/17
MZHO
10/11/17
INITIATION
Target $18
MZHO
Neutral
Cloudera initiated with a Neutral at Mizuho
Mizuho analyst Abhey Lamba initiated Cloudera with a Neutral and $18 price target citing valuation.
05/24/17
BOFA
05/24/17
INITIATION
Target $23
BOFA
Neutral
Cloudera initiated with a Neutral at BofA/Merrill
BofA/Merrill initiated Cloudera with a Neutral and a $23 price target.
05/23/17
05/23/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cloudera (CLDR) was initiated with an Overweight at JPMorgan, a Buy at Stifel and Deutsche Bank, a Market Perform at JMP Securities, an Equal Weight at Morgan Stanley, and a Neutral at Citi. 2. Emerald Expositions Events (EEX) was initiated with an Outperform at RBC Capital, an Overweight at Barclays, a Buy at BofA/Merrill and Deutsche Bank, as well as a Neutral at Goldman Sachs, Credit Suisse, and Baird. 3. Zymeworks (ZYME) was initiated with an Outperform at Wells Fargo, an Overweight at Barclays, and a Buy at Canaccord. 4. Carvana (CVNA) was initiated with an Outperform at William Blair, JMP Securities, BMO Capital, Wells Fargo, and Baird, as well as a Buy at BofA/Merrill and Citi. 5. J.B. Hunt (JBHT) initiated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/23/17
JMPS
05/23/17
INITIATION
JMPS
Market Perform
Cloudera initiated with a Market Perform at JMP Securities
JMP Securities analyst Greg McDowell started coverage of Cloudera with a Market Perform rating, citing valuation.
TSRO Tesaro
$117.91

-0.31 (-0.26%)

09/11/17
MSCO
09/11/17
NO CHANGE
MSCO
Overweight
Tesaro, Clovis pressured as by IO synergy questions, says Morgan Stanley
Morgan Stanley analyst Andrew Berens noted selloffs on Friday in shares of both Tesaro (TSRO) and Clovis (CLVS), which he attributed to investors questioning their drug's synergies with IO after the TOPACIO trial data on Tesaro's Zejula raised questions about treatment duration. Also, some investors view the current response rates as raising questions about the utility of combination strategies, said Berens. However, he is encouraged that triple negative breast cancer patients with WT BRCA seemed to respond to Zejula, which he believes could open up a much larger breast cancer opportunity than is currently modeled. Berens has Overweight ratings on Tesaro and Clovis shares.
09/11/17
SBSH
09/11/17
NO CHANGE
Target $216
SBSH
Buy
Tesaro's early PD-1 data look promising, says Citi
Citi analyst Robyn Karnauskas says the early safety and preliminary efficacy data from Tesaro's PD-1 molecule, TSR-042, look promising and comparable to existing PD-1s. The drug showed early anti-tumor activity, in-line with expectations, Karnauskas tells investors in a research note. She believes, however, that investors are likely to wait for durable data from larger patient population before assigning value to TSR-042. The analyst keeps a Buy rating on Tesaro with a $216 price target.
09/14/17
RBCM
09/14/17
INITIATION
Target $120
RBCM
Sector Perform
Tesaro initiated with a Sector Perform at RBC Capital
RBC Capital analyst Kennen MacKay initiated Tesaro with a Sector Perform and a $120 price target. Lynparza's all-comers label and Rubraca's third-to-market stance complicates the company's position, and valuation is fair on a standalone basis, wrote the analysis.
10/12/17
HCWC
10/12/17
INITIATION
Target $158
HCWC
Buy
Tesaro initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Edward White started Tesaro with a Buy rating and $158 price target. Investors are not giving the company enough credit for the "impressive" Zejula launch in the U.S. and its potential in other indications, White tells investors in a research note.
FTI TechnipFMC
$26.82

-0.45 (-1.65%)

09/11/17
09/11/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: DowDuPont (DWDP) initiated with a Buy at BofA/Merrill and an Underweight at Barclays. 2. Brookfield Infrastructure (BIP) initiated with an Outperform at BMO Capital. 3. Micron (MU) initiated with an Outperform at FBN Securities. 4. TechnipFMC (FTI) initiated with a Hold at HSBC. 5. Thor Industries (THO) initiated with a Hold at Aegis. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/12/17
JPMS
09/12/17
NO CHANGE
JPMS
JPMorgan's fall playbook includes downgrades of Precision, Tetra
JPMorgan analyst Sean Meakim laid out his Fall 2017 playbook for the Oil Services & Equipment space and downgraded both Precision Drilling (PDS) and Tetra Technologies (TTM) to Neutral from Overweight. The analyst removed his price targets for both names. Both stocks, despite underperforming year-to-date, have few upside catalysts, Meakim tells investors in a research note. He notes Precision is now the most levered land driller in his coverage universe and that an "M&A bailout of the whole company" is unlikely for Tetra. Meakim's top picks in the sector are TechnipFMC (FTI) and Halliburton (HAL) among large caps and Core Laboratories (CLB), MRC Global (MRC) and ProPetro Holding (PUMP) among small- and mid-caps.
10/02/17
SBSH
10/02/17
UPGRADE
Target $35
SBSH
Buy
TechnipFMC upgraded to Buy from Neutral at Citi
Citi analyst Michael Alsford upgraded TechnipFMC to Buy saying the shares, close to his "bear-case valuation," offer a "compelling" risk/reward at current levels. The analyst raised his price target for the shares to $35 from $29.40.
10/12/17
RAJA
10/12/17
INITIATION
RAJA
Market Perform
TechnipFMC coverage transferred with a Market Perform at Raymond James
Raymond James transferred coverage on TechnipFMC to Jean-Pierre Dmirdjian who continues to rate shares a Market Perform.
TCMD Tactile Systems
$30.99

-0.15 (-0.48%)

09/18/17
BTIG
09/18/17
DOWNGRADE
BTIG
Neutral
Tactile Systems downgraded to Neutral from Buy at BTIG
BTIG analyst Sean Lavin downgraded Tactile Systems based on valuation. Target remains $35.
10/03/17
WBLR
10/03/17
NO CHANGE
WBLR
Outperform
Tactile Systems can grow sales 20%-30% for several years, says William Blair
William Blair analyst Margaret Kaczor left investor meetings with Tactile Systems CFO Lynn Blake encouraged by the potential impact that the company's multiple strategic initiatives could have on near- and long-term growth. Tactile can grow 20%-30% on the top line for the next several years, Kaczor tells investors in a research note. She's confident the company can meet or beat her estimates for 2017 and 2018 and calls the stock one of the most compelling names in her coverage list. The analyst keeps an Outperform rating on Tactile Systems.
10/12/17
GUGG
10/12/17
INITIATION
Target $47
GUGG
Buy
Tactile Systems initiated with a Buy at Guggenheim
Guggenheim analyst Christopher Pasquale initiated Tactile Systems with a Buy and $47 price target.
08/08/17
ADAM
08/08/17
NO CHANGE
Target $37
ADAM
Buy
Tactile Systems price target raised to $37 from $28 at Canaccord
Canaccord analyst Jason Mills raised his price target on Tactile Systems to $37 from $28 following Q2 results. The company represents a solid, fundamentally sound growth company with strong results that reflect the experienced management team's ability to execute, said Mills, who reiterated his Buy rating on Tactile shares.

TODAY'S FREE FLY STORIES

GE

General Electric

$14.49

-0.01 (-0.07%)

18:49
02/23/18
02/23
18:49
02/23/18
18:49
Periodicals
General Electric could face DOJ action over subprime mortgages, Reuters says »

General Electric may face…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BEDU

Bright Scholar

$20.15

0.34 (1.72%)

18:30
02/23/18
02/23
18:30
02/23/18
18:30
Syndicate
Bright Scholar files to sell 10M American Depositary Shares »

Each ADS represents one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$132.02

2.11 (1.62%)

, CMD

Cantel Medical

$115.34

2.45 (2.17%)

18:03
02/23/18
02/23
18:03
02/23/18
18:03
Periodicals
J&J sterilization unit draws bids from Cantel Medical, Medtronic, Bloomberg says »

Cantel Medical (CMD) and…

JNJ

Johnson & Johnson

$132.02

2.11 (1.62%)

CMD

Cantel Medical

$115.34

2.45 (2.17%)

MDT

Medtronic

$80.39

-0.02 (-0.02%)

KKR

KKR

$21.96

0.18 (0.83%)

CG

Carlyle Group

$23.15

-0.1 (-0.43%)

MMM

3M

$237.02

1.02 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 08

    Mar

  • 14

    Mar

  • 23

    Mar

  • 23

    Apr

  • 30

    May

AET

Aetna

$175.55

0.49 (0.28%)

, CVS

CVS Health

$68.16

0.16 (0.24%)

18:00
02/23/18
02/23
18:00
02/23/18
18:00
Hot Stocks
Aetna: CVS deal part of long-term solution toward value-based system »

According to prepared…

AET

Aetna

$175.55

0.49 (0.28%)

CVS

CVS Health

$68.16

0.16 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 30

    May

MYND

MYnd Analytics

$2.60

0.0301 (1.17%)

17:56
02/23/18
02/23
17:56
02/23/18
17:56
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYND

MYnd Analytics

$2.60

0.0301 (1.17%)

17:55
02/23/18
02/23
17:55
02/23/18
17:55
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRV

ContraVir Pharmaceuticals

$0.27

0.0027 (1.02%)

17:43
02/23/18
02/23
17:43
02/23/18
17:43
Hot Stocks
Gabriele Cerrone reports 7.0% stake in ContraVir Pharma, may seek board changes »

The shares of common…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$40.98

0.09 (0.22%)

17:41
02/23/18
02/23
17:41
02/23/18
17:41
Periodicals
VW settles U.S. diesel suit just before trial, Reuters reports »

Volkswagen's U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IAC

IAC

$153.99

3.2 (2.12%)

17:40
02/23/18
02/23
17:40
02/23/18
17:40
Hot Stocks
Breaking Hot Stocks news story on IAC »

Barry Diller reports 8.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

SPG

Simon Property

$156.66

2.63 (1.71%)

17:37
02/23/18
02/23
17:37
02/23/18
17:37
Syndicate
Breaking Syndicate news story on Simon Property »

Simon Property files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FN

Fabrinet

$28.64

0.99 (3.58%)

17:35
02/23/18
02/23
17:35
02/23/18
17:35
Hot Stocks
Fabrinet director Frank Levinson buys 10,000 shares of company stock »

Frank Levinson, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 12

    Mar

  • 29

    Mar

CASI

Casi Pharmaceuticals

$3.85

0.1 (2.67%)

17:33
02/23/18
02/23
17:33
02/23/18
17:33
Syndicate
Breaking Syndicate news story on Casi Pharmaceuticals »

Casi Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXCM

Dexcom

$56.36

-0.04 (-0.07%)

, TNDM

TNDM

17:31
02/23/18
02/23
17:31
02/23/18
17:31
Hot Stocks
Breaking Hot Stocks news story on Dexcom, TNDM »

DexCom reports 5.6%…

DXCM

Dexcom

$56.36

-0.04 (-0.07%)

TNDM

TNDM

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 01

    Mar

  • 04

    Mar

IDXX

Idexx Laboratories

$187.61

3.75 (2.04%)

17:24
02/23/18
02/23
17:24
02/23/18
17:24
Hot Stocks
Idexx Laboratories director sells 4,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 04

    Mar

CYDY

CytoDyn

$0.72

0.02 (2.86%)

17:23
02/23/18
02/23
17:23
02/23/18
17:23
Syndicate
Breaking Syndicate news story on CytoDyn »

CytoDyn files $200M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRUS

Merus

17:23
02/23/18
02/23
17:23
02/23/18
17:23
Hot Stocks
Breaking Hot Stocks news story on Merus »

Biotechnology Value Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

MSG

Madison Square Garden

$231.97

2.41 (1.05%)

17:19
02/23/18
02/23
17:19
02/23/18
17:19
Hot Stocks
Silver Lake reports 4.9% stake in Madison Square Garden, may seek talks »

Silver Lake are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKL

Markel

$1,121.90

14.9 (1.35%)

17:12
02/23/18
02/23
17:12
02/23/18
17:12
Syndicate
Breaking Syndicate news story on Markel »

Markel files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BEDU

Bright Scholar

$20.15

0.34 (1.72%)

17:08
02/23/18
02/23
17:08
02/23/18
17:08
Syndicate
Bright Scholar files to sell 10M American Depositary Shares »

Each ADS represents one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$162.09

2.69 (1.69%)

, MYL

Mylan

$41.45

0.17 (0.41%)

17:04
02/23/18
02/23
17:04
02/23/18
17:04
Periodicals
PTAB denies Allergan's bid to dismiss restasis patent challenge, Bloomberg says »

Allergan's (AGN)…

AGN

Allergan

$162.09

2.69 (1.69%)

MYL

Mylan

$41.45

0.17 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 19

    Mar

  • 25

    Mar

  • 23

    Apr

  • 13

    Nov

SCHW

Charles Schwab

$52.74

0.71 (1.36%)

17:03
02/23/18
02/23
17:03
02/23/18
17:03
Hot Stocks
Charles Schwab appoints Joseph Martinetto as COO of the firm »

On February 22, the board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$69.02

1.38 (2.04%)

, BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

17:02
02/23/18
02/23
17:02
02/23/18
17:02
Hot Stocks
Kraft Heinz announces retirement of Warren Buffett from Board of Directors »

The Kraft Heinz Company…

KHC

Kraft Heinz

$69.02

1.38 (2.04%)

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

BUD

AB InBev

$107.25

1.91 (1.81%)

QSR

Restaurant Brands

$59.46

1.02 (1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 07

    Mar

  • 18

    Mar

SWX

Southwest Gas

$69.17

1.65 (2.44%)

17:02
02/23/18
02/23
17:02
02/23/18
17:02
Hot Stocks
Southwest Gas increases quarterly common stock dividend »

The board for Southwest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

MS

Morgan Stanley

$56.07

1.21 (2.21%)

, AAOI

Applied Optoelectronics

$28.02

0.51 (1.85%)

16:56
02/23/18
02/23
16:56
02/23/18
16:56
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley, Applied Optoelectronics »

Morgan Stanley reports…

MS

Morgan Stanley

$56.07

1.21 (2.21%)

AAOI

Applied Optoelectronics

$28.02

0.51 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 25

    Feb

  • 12

    Mar

  • 13

    Mar

  • 29

    Mar

HSBC

HSBC

$51.23

0.19 (0.37%)

16:49
02/23/18
02/23
16:49
02/23/18
16:49
Syndicate
Breaking Syndicate news story on HSBC »

HSBC files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.